Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Aug 23;10:264. doi: 10.1186/s13287-019-1365-z

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s). 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 7 — Upper panels: Representative photomicrographs of lung parenchyma stained with hematoxylin-eosin. (a) in the C group, lung architecture presents normal alveoli (A) and airways (AW); (b) in the CLP-SAL group, lung damage was observed, with areas of alveolar collapse (asterisk) and alveolar septal inflammation (arrows); (c) administration of nonpreconditioned AD-MSCs (CLP-AD-MSC) attenuated alveolar collapse (asterisk) and alveolar septal inflammation (arrows); and (d) administration of EPA-preconditioned AD-MSCs (CLP-AD-MSC-EPA) led to a further reduction in alveolar collapse (asterisk) and alveolar septal inflammation (arrows). Lower panels: Cumulative diffuse alveolar damage (DAD) score representing injury from alveolar collapse, interstitial edema, and septal inflammation. Values are given as medians (interquartile ranges) of 8 animals in each group. *Significantly different from C group (P <0.05). #Significantly different from CLP-SAL group (P <0.05). ‡Significantly different from CLP-AD-MSC group (P <0.05)